Identification of New Prognostic Markers and Therapeutic Targets for Non-Muscle Invasive Bladder Cancer: HER2 as a Potential Target Antigen

Bacillus Calmette–Guérin (BCG) is the gold standard adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). However, given the current global shortage of BCG, new treatments are needed. We evaluated tumor microenvironment markers as potential BCG alternatives for NMIBC treatment. Programm...

Descripción completa

Detalles Bibliográficos
Autores principales: Chae, Han Kyu, Nam, Wook, Kim, Han Gwun, Lim, Sharon, Noh, Byeong-Joo, Kim, So Won, Kang, Gil Hyun, Park, Jong Yeon, Eom, Dae-Woon, Kim, Sung Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167936/
https://www.ncbi.nlm.nih.gov/pubmed/35677058
http://dx.doi.org/10.3389/fimmu.2022.903297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167936/
https://www.ncbi.nlm.nih.gov/pubmed/35677058
http://dx.doi.org/10.3389/fimmu.2022.903297

Ejemplares similares